PMA device
Perceval PLUS Sutureless Heart Valve
Corcym S.r.l. · Heart-Valve, Non-Allograft Tissue (LWR, Class III) · First FDA decision Oct 7, 2022, newest Oct 7, 2022Aortic stenosisMitral regurgitationTricuspid regurgitation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
7
Naming "Perceval PLUS Sutureless"
MAUDE reports
280
Brand "Perceval PLUS Sutureless", since 2015
PubMed studies
0
Mentioning "Perceval PLUS Sutureless"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Perceval PLUS Sutureless Heart Valve
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Perceval PLUS Sutureless Heart ValvePMA supplement
P150011-S024 · Decided Oct 7, 2022 · 179 days after receipt · Normal 180 Day Track
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Perceval PLUS Sutureless", any status and sponsor, newest update first.
- Perceval Sutureless Implant Versus Standard-Aortic Valve ReplacementPivotal-lookingTerminated
Corcym S.r.lNot on our public-company list
NCT02673697 · 914 participants · Start Mar 22, 2016 · Primary completion Jan 17, 2020
Device: Perceval valve; other stented biological valve · For: Aortic Valve Disease; Aortic Stenosis
Sites: Indianapolis, Indiana; Portland, Maine; Cleveland, Ohio · 47 sites in all
- Clinical Data Collection on Perceval S Sutureless Prosthetic Aortic Valve in the Chinese PopulationStatus unknown
Corcym S.r.lNot on our public-company list
NCT06011148 · 80 participants (planned) · Start Dec 2024 · Primary completion Dec 2025
Device: Perceval S sutureless heart valve · For: Aortic Valve Disease
Corcym S.r.lNot on our public-company list
NCT01368666 · 658 participants · Start Feb 23, 2010 · Primary completion Oct 31, 2014
Device: Perceval S Valve Prosthesis · For: Aortic Valve Replacement
Sites: Graz, Austria; Vienna, Austria; Aalst, Belgium · 26 sites in all
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Perceval PLUS Sutureless", and for the whole product code for context.
This brand
280 reports: 24 malfunction, 248 injury, 8 death
Whole product code LWR
17,256 reports: 871 malfunction, 15,439 injury, 934 death
Newest reports for this brand
3004478276-2026-00176 · Received Oct 14, 2026 · Event dated Sep 14, 2026
Device type: Heart-Valve, Non-Allograft Tissue (LWR)
Device problem as coded: Leak/Splash
Patient problem as coded: Aortic Valve Insufficiency/ Regurgitation
3004478276-2026-00175 · Received Oct 13, 2026 · Event dated Sep 2, 2026
Device type: Heart-Valve, Non-Allograft Tissue (LWR)
Device problem as coded: Incomplete Coaptation
Patient problem as coded: Aortic Valve Insufficiency/ Regurgitation
3019892983-2026-00009 · Received Oct 9, 2026 · Event dated Sep 8, 2026
Device type: Heart-Valve, Non-Allograft Tissue (LWR)
Device problem as coded: Leak/Splash
Patient problem as coded: Aortic Valve Insufficiency/ Regurgitation
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0716-2017 · Started Oct 31, 2016
Reason given: Sorin Group USA, Inc. announces a voluntary field action for the Perceval Sutureless Heart Valve due to updated steps associated with the implantation procedure.
Cause as FDA categorized it: Use error · Device type: Heart-Valve, Non-Allograft Tissue (LWR)
Published research
The most relevant PubMed records for "Perceval PLUS Sutureless"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LWR.
- Edwards Pericardial Aortic Bioprosthesis and INSPIRIS RESILIA Aortic ValveEdwards Lifesciences, LLC · PMA 2022
- St. Jude Medical Biocor and Biocor Supra ValvesAbbott Medical · PMA 2012
- INSPIRIS RESILIA Aortic ValveEdwards Lifesciences, LLC · PMA 2026
- Mitroflow Aortic Pericardial Heart ValveCorcym Canada Corp · PMA 2019
- TRIFORMIS RESILIA Tricuspid ValveEdwards Lifesciences, LLC · PMA 2026
- Perceval Sutureless Heart Valve, Perceval Plus Sutureless Heart ValveCorcym S.r.l. · PMA 2025
- Sjm Biocor Valve / Sjm Biocor Supra ValveAbbott Medical · PMA 2016
- Ats 3F Aortic Bioprosthesis Model 1000Medtronic, Inc. · PMA 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.